The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2022 | Highlights of WCLC 2022
Neal Sean McCall, MD, Winship Cancer Institute, Emory University, Atlanta, GA, shares his highlights from the IASLC 2022 World Conference on Lung Cancer congress, including on oligometastatic disease sessions, the use of ablative local therapies and designing trials in the future in order to isolate different groups of patients to understand disease biology between subgroups of patients. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.
